Global Oral Proteins and Peptides Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oral Proteins and Peptides Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oral Proteins and Peptides by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oral Proteins and Peptides by Country/Region, 2017, 2022 & 2028

2.2 Oral Proteins and Peptides Segment by Type

2.2.1 Linaclotide

2.2.2 Calcitonin

2.2.3 Insulin

2.2.4 Octreotide

2.3 Oral Proteins and Peptides Sales by Type

2.3.1 Global Oral Proteins and Peptides Sales Market Share by Type (2017-2022)

2.3.2 Global Oral Proteins and Peptides Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oral Proteins and Peptides Sale Price by Type (2017-2022)

2.4 Oral Proteins and Peptides Segment by Application

2.4.1 Gastric & Digestive Disorders

2.4.2 Bone Diseases

2.4.3 Diabetes

2.4.4 Hormonal Disorders

2.5 Oral Proteins and Peptides Sales by Application

2.5.1 Global Oral Proteins and Peptides Sale Market Share by Application (2017-2022)

2.5.2 Global Oral Proteins and Peptides Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oral Proteins and Peptides Sale Price by Application (2017-2022)

3 Global Oral Proteins and Peptides by Company

3.1 Global Oral Proteins and Peptides Breakdown Data by Company

3.1.1 Global Oral Proteins and Peptides Annual Sales by Company (2020-2022)

3.1.2 Global Oral Proteins and Peptides Sales Market Share by Company (2020-2022)

3.2 Global Oral Proteins and Peptides Annual Revenue by Company (2020-2022)

3.2.1 Global Oral Proteins and Peptides Revenue by Company (2020-2022)

3.2.2 Global Oral Proteins and Peptides Revenue Market Share by Company (2020-2022)

3.3 Global Oral Proteins and Peptides Sale Price by Company

3.4 Key Manufacturers Oral Proteins and Peptides Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oral Proteins and Peptides Product Location Distribution

3.4.2 Players Oral Proteins and Peptides Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oral Proteins and Peptides by Geographic Region

4.1 World Historic Oral Proteins and Peptides Market Size by Geographic Region (2017-2022)

4.1.1 Global Oral Proteins and Peptides Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oral Proteins and Peptides Annual Revenue by Geographic Region

4.2 World Historic Oral Proteins and Peptides Market Size by Country/Region (2017-2022)

4.2.1 Global Oral Proteins and Peptides Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oral Proteins and Peptides Annual Revenue by Country/Region

4.3 Americas Oral Proteins and Peptides Sales Growth

4.4 APAC Oral Proteins and Peptides Sales Growth

4.5 Europe Oral Proteins and Peptides Sales Growth

4.6 Middle East & Africa Oral Proteins and Peptides Sales Growth

5 Americas

5.1 Americas Oral Proteins and Peptides Sales by Country

5.1.1 Americas Oral Proteins and Peptides Sales by Country (2017-2022)

5.1.2 Americas Oral Proteins and Peptides Revenue by Country (2017-2022)

5.2 Americas Oral Proteins and Peptides Sales by Type

5.3 Americas Oral Proteins and Peptides Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oral Proteins and Peptides Sales by Region

6.1.1 APAC Oral Proteins and Peptides Sales by Region (2017-2022)

6.1.2 APAC Oral Proteins and Peptides Revenue by Region (2017-2022)

6.2 APAC Oral Proteins and Peptides Sales by Type

6.3 APAC Oral Proteins and Peptides Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oral Proteins and Peptides by Country

7.1.1 Europe Oral Proteins and Peptides Sales by Country (2017-2022)

7.1.2 Europe Oral Proteins and Peptides Revenue by Country (2017-2022)

7.2 Europe Oral Proteins and Peptides Sales by Type

7.3 Europe Oral Proteins and Peptides Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oral Proteins and Peptides by Country

8.1.1 Middle East & Africa Oral Proteins and Peptides Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oral Proteins and Peptides Revenue by Country (2017-2022)

8.2 Middle East & Africa Oral Proteins and Peptides Sales by Type

8.3 Middle East & Africa Oral Proteins and Peptides Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oral Proteins and Peptides

10.3 Manufacturing Process Analysis of Oral Proteins and Peptides

10.4 Industry Chain Structure of Oral Proteins and Peptides

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oral Proteins and Peptides Distributors

11.3 Oral Proteins and Peptides Customer

12 World Forecast Review for Oral Proteins and Peptides by Geographic Region

12.1 Global Oral Proteins and Peptides Market Size Forecast by Region

12.1.1 Global Oral Proteins and Peptides Forecast by Region (2023-2028)

12.1.2 Global Oral Proteins and Peptides Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oral Proteins and Peptides Forecast by Type

12.7 Global Oral Proteins and Peptides Forecast by Application

13 Key Players Analysis

13.1 Allergan

13.1.1 Allergan Company Information

13.1.2 Allergan Oral Proteins and Peptides Product Offered

13.1.3 Allergan Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Allergan Main Business Overview

13.1.5 Allergan Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Oral Proteins and Peptides Product Offered

13.2.3 AstraZeneca Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Biocon

13.3.1 Biocon Company Information

13.3.2 Biocon Oral Proteins and Peptides Product Offered

13.3.3 Biocon Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biocon Main Business Overview

13.3.5 Biocon Latest Developments

13.4 Generex Biotechnology

13.4.1 Generex Biotechnology Company Information

13.4.2 Generex Biotechnology Oral Proteins and Peptides Product Offered

13.4.3 Generex Biotechnology Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Generex Biotechnology Main Business Overview

13.4.5 Generex Biotechnology Latest Developments

13.5 Novo Nordisk

13.5.1 Novo Nordisk Company Information

13.5.2 Novo Nordisk Oral Proteins and Peptides Product Offered

13.5.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novo Nordisk Main Business Overview

13.5.5 Novo Nordisk Latest Developments

13.6 Synergy Pharmaceuticals

13.6.1 Synergy Pharmaceuticals Company Information

13.6.2 Synergy Pharmaceuticals Oral Proteins and Peptides Product Offered

13.6.3 Synergy Pharmaceuticals Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Synergy Pharmaceuticals Main Business Overview

13.6.5 Synergy Pharmaceuticals Latest Developments

13.7 Tarsa Therapeutics

13.7.1 Tarsa Therapeutics Company Information

13.7.2 Tarsa Therapeutics Oral Proteins and Peptides Product Offered

13.7.3 Tarsa Therapeutics Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Tarsa Therapeutics Main Business Overview

13.7.5 Tarsa Therapeutics Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Oral Proteins and Peptides Product Offered

13.8.3 Sanofi Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 Hoffmann-La Roche

13.9.1 Hoffmann-La Roche Company Information

13.9.2 Hoffmann-La Roche Oral Proteins and Peptides Product Offered

13.9.3 Hoffmann-La Roche Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hoffmann-La Roche Main Business Overview

13.9.5 Hoffmann-La Roche Latest Developments

13.10 Synthetic Biologics

13.10.1 Synthetic Biologics Company Information

13.10.2 Synthetic Biologics Oral Proteins and Peptides Product Offered

13.10.3 Synthetic Biologics Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Synthetic Biologics Main Business Overview

13.10.5 Synthetic Biologics Latest Developments

13.11 Hovione

13.11.1 Hovione Company Information

13.11.2 Hovione Oral Proteins and Peptides Product Offered

13.11.3 Hovione Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Hovione Main Business Overview

13.11.5 Hovione Latest Developments

13.12 Novartis

13.12.1 Novartis Company Information

13.12.2 Novartis Oral Proteins and Peptides Product Offered

13.12.3 Novartis Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Novartis Main Business Overview

13.12.5 Novartis Latest Developments

14 Research Findings and Conclusion

Table 1. Oral Proteins and Peptides Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oral Proteins and Peptides Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Linaclotide

Table 4. Major Players of Calcitonin

Table 5. Major Players of Insulin

Table 6. Major Players of Octreotide

Table 7. Global Oral Proteins and Peptides Sales by Type (2017-2022) & (K MT)

Table 8. Global Oral Proteins and Peptides Sales Market Share by Type (2017-2022)

Table 9. Global Oral Proteins and Peptides Revenue by Type (2017-2022) & ($ million)

Table 10. Global Oral Proteins and Peptides Revenue Market Share by Type (2017-2022)

Table 11. Global Oral Proteins and Peptides Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Oral Proteins and Peptides Sales by Application (2017-2022) & (K MT)

Table 13. Global Oral Proteins and Peptides Sales Market Share by Application (2017-2022)

Table 14. Global Oral Proteins and Peptides Revenue by Application (2017-2022)

Table 15. Global Oral Proteins and Peptides Revenue Market Share by Application (2017-2022)

Table 16. Global Oral Proteins and Peptides Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Oral Proteins and Peptides Sales by Company (2020-2022) & (K MT)

Table 18. Global Oral Proteins and Peptides Sales Market Share by Company (2020-2022)

Table 19. Global Oral Proteins and Peptides Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Oral Proteins and Peptides Revenue Market Share by Company (2020-2022)

Table 21. Global Oral Proteins and Peptides Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Oral Proteins and Peptides Producing Area Distribution and Sales Area

Table 23. Players Oral Proteins and Peptides Products Offered

Table 24. Oral Proteins and Peptides Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Oral Proteins and Peptides Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Oral Proteins and Peptides Sales Market Share Geographic Region (2017-2022)

Table 29. Global Oral Proteins and Peptides Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Oral Proteins and Peptides Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Oral Proteins and Peptides Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Oral Proteins and Peptides Sales Market Share by Country/Region (2017-2022)

Table 33. Global Oral Proteins and Peptides Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Oral Proteins and Peptides Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Oral Proteins and Peptides Sales by Country (2017-2022) & (K MT)

Table 36. Americas Oral Proteins and Peptides Sales Market Share by Country (2017-2022)

Table 37. Americas Oral Proteins and Peptides Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Oral Proteins and Peptides Revenue Market Share by Country (2017-2022)

Table 39. Americas Oral Proteins and Peptides Sales by Type (2017-2022) & (K MT)

Table 40. Americas Oral Proteins and Peptides Sales Market Share by Type (2017-2022)

Table 41. Americas Oral Proteins and Peptides Sales by Application (2017-2022) & (K MT)

Table 42. Americas Oral Proteins and Peptides Sales Market Share by Application (2017-2022)

Table 43. APAC Oral Proteins and Peptides Sales by Region (2017-2022) & (K MT)

Table 44. APAC Oral Proteins and Peptides Sales Market Share by Region (2017-2022)

Table 45. APAC Oral Proteins and Peptides Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Oral Proteins and Peptides Revenue Market Share by Region (2017-2022)

Table 47. APAC Oral Proteins and Peptides Sales by Type (2017-2022) & (K MT)

Table 48. APAC Oral Proteins and Peptides Sales Market Share by Type (2017-2022)

Table 49. APAC Oral Proteins and Peptides Sales by Application (2017-2022) & (K MT)

Table 50. APAC Oral Proteins and Peptides Sales Market Share by Application (2017-2022)

Table 51. Europe Oral Proteins and Peptides Sales by Country (2017-2022) & (K MT)

Table 52. Europe Oral Proteins and Peptides Sales Market Share by Country (2017-2022)

Table 53. Europe Oral Proteins and Peptides Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Oral Proteins and Peptides Revenue Market Share by Country (2017-2022)

Table 55. Europe Oral Proteins and Peptides Sales by Type (2017-2022) & (K MT)

Table 56. Europe Oral Proteins and Peptides Sales Market Share by Type (2017-2022)

Table 57. Europe Oral Proteins and Peptides Sales by Application (2017-2022) & (K MT)

Table 58. Europe Oral Proteins and Peptides Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Oral Proteins and Peptides Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Oral Proteins and Peptides Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Oral Proteins and Peptides Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Oral Proteins and Peptides Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Oral Proteins and Peptides Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Oral Proteins and Peptides

Table 68. Key Market Challenges & Risks of Oral Proteins and Peptides

Table 69. Key Industry Trends of Oral Proteins and Peptides

Table 70. Oral Proteins and Peptides Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Oral Proteins and Peptides Distributors List

Table 73. Oral Proteins and Peptides Customer List

Table 74. Global Oral Proteins and Peptides Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Oral Proteins and Peptides Sales Market Forecast by Region

Table 76. Global Oral Proteins and Peptides Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Oral Proteins and Peptides Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Oral Proteins and Peptides Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Oral Proteins and Peptides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Oral Proteins and Peptides Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Oral Proteins and Peptides Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Oral Proteins and Peptides Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Oral Proteins and Peptides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Oral Proteins and Peptides Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Oral Proteins and Peptides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Oral Proteins and Peptides Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Oral Proteins and Peptides Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Oral Proteins and Peptides Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Oral Proteins and Peptides Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Oral Proteins and Peptides Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Oral Proteins and Peptides Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Oral Proteins and Peptides Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Oral Proteins and Peptides Revenue Market Share Forecast by Application (2023-2028)

Table 94. Allergan Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 95. Allergan Oral Proteins and Peptides Product Offered

Table 96. Allergan Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. Allergan Main Business

Table 98. Allergan Latest Developments

Table 99. AstraZeneca Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 100. AstraZeneca Oral Proteins and Peptides Product Offered

Table 101. AstraZeneca Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. AstraZeneca Main Business

Table 103. AstraZeneca Latest Developments

Table 104. Biocon Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 105. Biocon Oral Proteins and Peptides Product Offered

Table 106. Biocon Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Biocon Main Business

Table 108. Biocon Latest Developments

Table 109. Generex Biotechnology Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 110. Generex Biotechnology Oral Proteins and Peptides Product Offered

Table 111. Generex Biotechnology Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. Generex Biotechnology Main Business

Table 113. Generex Biotechnology Latest Developments

Table 114. Novo Nordisk Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 115. Novo Nordisk Oral Proteins and Peptides Product Offered

Table 116. Novo Nordisk Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. Novo Nordisk Main Business

Table 118. Novo Nordisk Latest Developments

Table 119. Synergy Pharmaceuticals Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 120. Synergy Pharmaceuticals Oral Proteins and Peptides Product Offered

Table 121. Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 122. Synergy Pharmaceuticals Main Business

Table 123. Synergy Pharmaceuticals Latest Developments

Table 124. Tarsa Therapeutics Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 125. Tarsa Therapeutics Oral Proteins and Peptides Product Offered

Table 126. Tarsa Therapeutics Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 127. Tarsa Therapeutics Main Business

Table 128. Tarsa Therapeutics Latest Developments

Table 129. Sanofi Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 130. Sanofi Oral Proteins and Peptides Product Offered

Table 131. Sanofi Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 132. Sanofi Main Business

Table 133. Sanofi Latest Developments

Table 134. Hoffmann-La Roche Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 135. Hoffmann-La Roche Oral Proteins and Peptides Product Offered

Table 136. Hoffmann-La Roche Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 137. Hoffmann-La Roche Main Business

Table 138. Hoffmann-La Roche Latest Developments

Table 139. Synthetic Biologics Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 140. Synthetic Biologics Oral Proteins and Peptides Product Offered

Table 141. Synthetic Biologics Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 142. Synthetic Biologics Main Business

Table 143. Synthetic Biologics Latest Developments

Table 144. Hovione Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 145. Hovione Oral Proteins and Peptides Product Offered

Table 146. Hovione Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 147. Hovione Main Business

Table 148. Hovione Latest Developments

Table 149. Novartis Basic Information, Oral Proteins and Peptides Manufacturing Base, Sales Area and Its Competitors

Table 150. Novartis Oral Proteins and Peptides Product Offered

Table 151. Novartis Oral Proteins and Peptides Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 152. Novartis Main Business

Table 153. Novartis Latest Developments

List of Figures

Figure 1. Picture of Oral Proteins and Peptides

Figure 2. Oral Proteins and Peptides Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oral Proteins and Peptides Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Oral Proteins and Peptides Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oral Proteins and Peptides Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Linaclotide

Figure 10. Product Picture of Calcitonin

Figure 11. Product Picture of Insulin

Figure 12. Product Picture of Octreotide

Figure 13. Global Oral Proteins and Peptides Sales Market Share by Type in 2021

Figure 14. Global Oral Proteins and Peptides Revenue Market Share by Type (2017-2022)

Figure 15. Oral Proteins and Peptides Consumed in Gastric & Digestive Disorders

Figure 16. Global Oral Proteins and Peptides Market: Gastric & Digestive Disorders (2017-2022) & (K MT)

Figure 17. Oral Proteins and Peptides Consumed in Bone Diseases

Figure 18. Global Oral Proteins and Peptides Market: Bone Diseases (2017-2022) & (K MT)

Figure 19. Oral Proteins and Peptides Consumed in Diabetes

Figure 20. Global Oral Proteins and Peptides Market: Diabetes (2017-2022) & (K MT)

Figure 21. Oral Proteins and Peptides Consumed in Hormonal Disorders

Figure 22. Global Oral Proteins and Peptides Market: Hormonal Disorders (2017-2022) & (K MT)

Figure 23. Global Oral Proteins and Peptides Sales Market Share by Application (2017-2022)

Figure 24. Global Oral Proteins and Peptides Revenue Market Share by Application in 2021

Figure 25. Oral Proteins and Peptides Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Oral Proteins and Peptides Revenue Market Share by Company in 2021

Figure 27. Global Oral Proteins and Peptides Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Oral Proteins and Peptides Revenue Market Share by Geographic Region in 2021

Figure 29. Global Oral Proteins and Peptides Sales Market Share by Region (2017-2022)

Figure 30. Global Oral Proteins and Peptides Revenue Market Share by Country/Region in 2021

Figure 31. Americas Oral Proteins and Peptides Sales 2017-2022 (K MT)

Figure 32. Americas Oral Proteins and Peptides Revenue 2017-2022 ($ Millions)

Figure 33. APAC Oral Proteins and Peptides Sales 2017-2022 (K MT)

Figure 34. APAC Oral Proteins and Peptides Revenue 2017-2022 ($ Millions)

Figure 35. Europe Oral Proteins and Peptides Sales 2017-2022 (K MT)

Figure 36. Europe Oral Proteins and Peptides Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Oral Proteins and Peptides Sales 2017-2022 (K MT)

Figure 38. Middle East & Africa Oral Proteins and Peptides Revenue 2017-2022 ($ Millions)

Figure 39. Americas Oral Proteins and Peptides Sales Market Share by Country in 2021

Figure 40. Americas Oral Proteins and Peptides Revenue Market Share by Country in 2021

Figure 41. United States Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Oral Proteins and Peptides Sales Market Share by Region in 2021

Figure 46. APAC Oral Proteins and Peptides Revenue Market Share by Regions in 2021

Figure 47. China Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Oral Proteins and Peptides Sales Market Share by Country in 2021

Figure 54. Europe Oral Proteins and Peptides Revenue Market Share by Country in 2021

Figure 55. Germany Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Oral Proteins and Peptides Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Oral Proteins and Peptides Revenue Market Share by Country in 2021

Figure 62. Egypt Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Oral Proteins and Peptides Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Oral Proteins and Peptides in 2021

Figure 68. Manufacturing Process Analysis of Oral Proteins and Peptides

Figure 69. Industry Chain Structure of Oral Proteins and Peptides

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles